Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors.

Sayer R, Law E, Connelly PJ, Breen KC.

Clin Biochem. 2004 Feb;37(2):98-104.

PMID:
14725939
[PubMed - indexed for MEDLINE]
2.

Acetylcholinesterase in Alzheimer's disease.

Talesa VN.

Mech Ageing Dev. 2001 Nov;122(16):1961-9. Review.

PMID:
11589914
[PubMed - indexed for MEDLINE]
3.

RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?

Sramek JJ, Cutler NR.

Alzheimer Dis Assoc Disord. 2000 Oct-Dec;14(4):216-27. Review.

PMID:
11186600
[PubMed - indexed for MEDLINE]
4.

[Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease].

Patocka J, Strunecká A, Rípová D.

Cesk Fysiol. 2001 Feb;50(1):4-10. Review. Czech.

PMID:
11268561
[PubMed - indexed for MEDLINE]
5.

Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.

Piccardi M, Congiu D, Squassina A, Manconi F, Putzu PF, Mereu RM, Chillotti C, Del Zompo M.

Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):895-9.

PMID:
17503475
[PubMed - indexed for MEDLINE]
6.

In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.

Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR.

Ann Neurol. 2006 Jan;59(1):13-20.

PMID:
16278840
[PubMed - indexed for MEDLINE]
7.

A monoclonal antibody assay technique for plasma and red cell acetylcholinesterase activity in Alzheimer's disease.

St Clair DM, Brock DJ, Barron L.

J Neurol Sci. 1986 Apr;73(2):169-76.

PMID:
2939202
[PubMed - indexed for MEDLINE]
8.

Developing a simple laboratory test for Alzheimer's disease: measuring acetylcholinesterase in saliva - a pilot study.

Boston PF, Gopalkaje K, Manning L, Middleton L, Loxley M.

Int J Geriatr Psychiatry. 2008 Apr;23(4):439-40. No abstract available.

PMID:
17702052
[PubMed - indexed for MEDLINE]
9.

Salivary acetylcholinesterase as a biomarker for organophosphate exposure.

Ng V, Koh D, Wee A, Chia SE.

Occup Med (Lond). 2009 Mar;59(2):120-2. doi: 10.1093/occmed/kqn164. Epub 2009 Jan 2.

PMID:
19122189
[PubMed - indexed for MEDLINE]
Free Article
10.

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.

Drugs Aging. 2004;21(7):453-78. Review.

PMID:
15132713
[PubMed - indexed for MEDLINE]
11.

Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.

DeKosky ST, Scheff SW, Markesbery WR.

Neurology. 1985 Oct;35(10):1425-31.

PMID:
4033925
[PubMed - indexed for MEDLINE]
12.

Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.

Bartorelli L, Giraldi C, Saccardo M, Cammarata S, Bottini G, Fasanaro AM, Trequattrini A; Upgrade Study Group.

Curr Med Res Opin. 2005 Nov;21(11):1809-18.

PMID:
16307702
[PubMed - indexed for MEDLINE]
13.

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease.

Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR.

Neurology. 1999 Mar 10;52(4):691-9.

PMID:
10078712
[PubMed - indexed for MEDLINE]
14.

Acetylcholinesterase and its inhibition in Alzheimer disease.

Lane RM, Kivipelto M, Greig NH.

Clin Neuropharmacol. 2004 May-Jun;27(3):141-9. Review.

PMID:
15190239
[PubMed - indexed for MEDLINE]
15.

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.

Appleyard ME, Smith AD, Berman P, Wilcock GK, Esiri MM, Neary D, Bowen DM.

Brain. 1987 Oct;110 ( Pt 5):1309-22.

PMID:
3676702
[PubMed - indexed for MEDLINE]
16.

The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.

Rees TM, Brimijoin S.

Drugs Today (Barc). 2003 Jan;39(1):75-83. Review.

PMID:
12669110
[PubMed - indexed for MEDLINE]
17.

Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.

Darreh-Shori T, Hellström-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A.

J Neurochem. 2004 Mar;88(5):1102-13.

PMID:
15009666
[PubMed - indexed for MEDLINE]
18.

Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.

Suh DC, Arcona S, Thomas SK, Powers C, Rabinowicz AL, Shin H, Mirski D.

Drugs Aging. 2004;21(6):395-403.

PMID:
15084141
[PubMed - indexed for MEDLINE]
19.

Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease.

Herholz K.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S25-9. doi: 10.1007/s00259-007-0699-4. Review.

PMID:
18196237
[PubMed - indexed for MEDLINE]
20.

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, Dekosky ST, Moore RY.

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9.

PMID:
15716518
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk